Bisphophonates Prevent Bone Loss Associated with Denosumab Treatment Discontinuation

被引：0
|
作者：
Belen Zanchetta, Maria [1 ]
Pelegrin, Carolina [1 ]
Silveira, Fernando [2 ]
Bogado, Cesar [2 ]
Zanchetta, Jose [2 ]
Salerni, Helena [3 ]
Costanzo, Pablo [3 ]
机构：
[1] Univ Salvador, Buenos Aires, DF, Argentina
[2] IDIM, Buenos Aires, DF, Argentina
[3] CICEMO, Buenos Aires, DF, Argentina
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2019年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
FRI-781
引用
收藏
页码：114 / 115
页数：2
相关论文
共 50 条
  • [1] Use of bisphosphonates to prevent bone loss with denosumab discontinuation: observations from clinical practice
    Duge, Leanne
    Dickens, Laura Thomason
    Jain, Rajesh
    Vokes, Tamara J.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2024, 39 : 160 - 160
  • [2] Effect of risedronate on bone loss at discontinuation of denosumab
    Laroche, Michel
    Couture, Guillaume
    Ruyssen-Witrand, Adeline
    Constantin, Arnaud
    Degboe, Yannick
    BONE REPORTS, 2020, 13
  • [3] Bone loss after discontinuation of denosumab: the devil is in the details
    Minisola, Salvatore
    Cipriani, Cristiana
    Colangelo, Luciano
    Pepe, Jessica
    JOURNAL OF BONE AND MINERAL RESEARCH, 2024, 39 (01) : 3 - 7
  • [4] Bone Matrix Mineralization After Denosumab Treatment Discontinuation.
    Brown, Jacques
    Dempster, David
    Yue, Susan
    Rizzo, Sebastien
    Farlay, Delphine
    Wagman, Rachel
    Yin, Xiang
    Boivin, Georges
    JOURNAL OF BONE AND MINERAL RESEARCH, 2017, 32 : S406 - S406
  • [5] TRANSITIONING TO ALENDRONATE AFTER LONG-TERM DENOSUMAB TREATMENT MAY PREVENT BONE LOSS
    Tsagareli, M.
    Giorgadze, E.
    Sulikashvili, T.
    Jeiranashvili, N.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2022, 34 (SUPPL 1) : S302 - S302
  • [6] Zoledronate Sequential Therapy After Denosumab Discontinuation to Prevent Bone Mineral Density Reduction
    Lee, Chia-Che
    Wang, Chen-Yu
    Yen, Hung-Kuan
    Hung, Chih-Chien
    Lai, Cheng-Yo
    Hu, Ming-Hsiao
    Wang, Ting-Ming
    Li, Chung-Yi
    Fu, Shau-Huai
    JAMA NETWORK OPEN, 2024, 7 (11)
  • [7] Oral vs Intravenous Bisphosphonates for Preventing Bone Loss After Denosumab Discontinuation
    Dickens, Laura
    Vokes, Tamara
    JOURNAL OF BONE AND MINERAL RESEARCH, 2019, 34 : 182 - 183
  • [8] BONE LOSS AND NEW FRACTURES WITH DENOSUMAB TREATMENT
    Sanguesa, C.
    Casafont-Sole, I.
    Nack, A.
    Holgado Perez, S.
    Martinez-Morillo, M.
    Aparicio Rovira, M.
    Prior-Espanol, A.
    Aparicio Espinar, M.
    Riveros, A.
    Mateo, L.
    Olive, A.
    Gifre, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1754 - 1755
  • [9] DISCONTINUATION OF DENOSUMAB RESULTS IN RAPID INCREASE OF BONE RESORPTION AND LOSS OF BONE MINERAL DENSITY GAIN
    Cokolic, M.
    Krajnc, M.
    OSTEOPOROSIS INTERNATIONAL, 2020, 31 (SUPPL 1) : S84 - S84
  • [10] Denosumab In Cancer Treatment-Induced Bone Loss
    Muir, Victoria J.
    Scott, Lesley J.
    BIODRUGS, 2010, 24 (06) : 379 - 386
12345